experts confronted on shared strategies in favor of health

Apr52022

The 14th National Pharma Forum “Research, innovation, access to Pharmacology”, organized by the Italian Society of Pharmacology (SIF), opens on Wednesday April 6

It opens on Wednesday April 6 14th National Pharmaceutical Industry Forum “Research, Innovation, Access to Pharmacology”, organized by the Italian Society of Pharmacology (SIF) to promote dialogue and partnership between the protagonists of the pharmaceutical world, from preclinical and clinical scientific research to commercialization on the Marlet.
The format of the event includes, alongside the conferences, sessions where the speakers will not make a formal presentation, but a joint discussion coordinated by the moderators and stimulated by the participating audience. The participation of speakers and moderators is free and the profits of the conference will be entirely donated to the Italian Society of Pharmacology for the creation of scholarships for young researchers. The media partner for the event will be Edra.

Themes and focus of the National Pharma Forum

How to respond to current social and health challenges? What common strategies to promote the health of all citizens? These are some questions that the 14th National Pharmaceutical Industry Forum to be held in Rome from April 6-8, 2022, the only window in Italy for a 360° look at drugs. Experts from the world of the Academy, the Istituto Superiore de Sanità, industry, AIFA and EMA, public and private research participate. Round tables and conferences will be held at the Hotel Villa Pamphili in Rome which will stimulate debate on the most current problems in search of shared solutions. The President of the Italian Society of Pharmacology Giorgio Racagni he comments on the meeting as follows: “We will tackle some of the most difficult questions from a technical and scientific point of view. The importance of technology, digital, professional and managerial skills to achieve a more effective articulation between preclinical and clinical research, data analysis and programming”.
Among the speakers of the forum stand out Antonio GaudiosoHead of the Technical Secretariat of the Ministry of Health; Francois LocatelliPresident of the Superior Health Council; Nicoletta LuppiPresident and CEO of MSD Italy; Nicholas MagriniDirector General of AIFA; Marie Cristina MessaMinister for University and Research; Anna Teresa PalamaraDirector of the Department of Infectious Diseases, National Institute of Health; Giorgio PaluPresident of AIFA; Massimo Scaccabarozzi, President of Farmindustria. The subjects on which they will debate are numerous and substantial: from innovation, therapeutic equivalence and superimposition to the simplification and digitization of clinical research up to the opportunities of PNRRfrom the promotion of preclinical, clinical and pharmacological health research by public and private institutions to the role of Real world proof in the registration, reimbursement and renegotiation of medicines. If it is true that science proceeds by trial and error and that there is no scientific method that does not start from the observation of reality, the point will not be missing on the effectiveness of anti-Covid vaccines. -19, on the management of the pandemic and the comparison on the lessons that the emergency experience can give us, first of all, on how to simplify and improve clinical research, but also on the importance of correct communication in health care.
More information on the program is available at the following link: https://www.sifweb.org/eventi/eventi_SIF/14-forum-nazionale-pharma-ricerca-in Tecnologia-Access-in-farmacologia-2022-04 -06

.

Add Comment